Youssef Roman to Humans
This is a "connection" page, showing publications Youssef Roman has written about Humans.
Connection Strength
0.721
-
Carter MW, Roman YM. Perspectives on the Epidemiology of Hyperuricemia and Gout in Older Adults. Sr Care Pharm. 2025 Sep 01; 40(9):365-372.
Score: 0.043
-
Roman Y. Bridging the United States population diversity gaps in clinical research: roadmap to precision health and reducing health disparities. Per Med. 2025 Jun; 22(3):193-203.
Score: 0.042
-
Roman YM. Pharmacogenomics and rare diseases: optimizing drug development and personalized therapeutics. Pharmacogenomics. 2025 Feb-Mar; 26(3-4):121-128.
Score: 0.042
-
Hang Y, Lee C, Roman YM. Assessing the clinical utility of major indices for nonalcoholic fatty liver disease in East?Asian populations. Biomark Med. 2023 04; 17(8):445-454.
Score: 0.037
-
Alrajeh K, AlAzzeh O, Roman Y. The frequency of major ABCG2, SLCO1B1 and CYP2C9 variants in Asian, Native Hawaiian and Pacific Islander women subgroups: implications for personalized statins dosing. Pharmacogenomics. 2023 05; 24(7):381-398.
Score: 0.037
-
Vo V, Lopez G, Malay S, Roman YM. Cardiovascular Risk Factors Among Asian Americans: Perspectives on the Role of Acculturation in Cardiovascular Diseases Health Disparities. J Immigr Minor Health. 2024 Apr; 26(2):409-420.
Score: 0.037
-
AlAzzeh O, Roman YM. The frequency of rs2231142 in ABCG2 among Native Hawaiian and Pacific Islander subgroups: implications for personalized rosuvastatin dosing. Pharmacogenomics. 2023 02; 24(3):173-182.
Score: 0.036
-
Alrajeh K, Roman YM. The frequency of rs2231142 in ABCG2?among Asian subgroups: implications for personalized rosuvastatin dosing. Pharmacogenomics. 2023 01; 24(1):15-26.
Score: 0.036
-
Roman YM. Moving the Needle in Gout Management: The Role of Culture, Diet, Genetics, and Personalized Patient Care Practices. Nutrients. 2022 Aug 31; 14(17).
Score: 0.035
-
Roman YM. COVID-19 pandemic: the role of community-based pharmacy practice in health equity. Int J Clin Pharm. 2022 Oct; 44(5):1211-1215.
Score: 0.034
-
Alrajeh KY, Roman YM. The frequency of major CYP2C19 genetic polymorphisms in women of Asian, Native Hawaiian?and Pacific Islander subgroups. Per Med. 2022 07; 19(4):327-339.
Score: 0.034
-
Anderson AN, Chan AR, Roman YM. Pharmacogenomics and clinical cultural competency: pathway to overcome the limitations of race. Pharmacogenomics. 2022 04; 23(6):363-370.
Score: 0.034
-
Coronado G, Chio-Lauri J, Cruz RD, Roman YM. Health Disparities of Cardiometabolic Disorders Among Filipino Americans: Implications for Health Equity and Community-Based Genetic Research. J Racial Ethn Health Disparities. 2022 12; 9(6):2560-2567.
Score: 0.033
-
Roman Y. The United States 2020 Census data: implications for precision medicine and the?research landscape. Per Med. 2022 01; 19(1):5-8.
Score: 0.033
-
Roman YM, Lor K, Xiong T, Culhane-Pera K, Straka RJ. Gout prevalence in the Hmong: a?prime example of health disparity and the role of community-based genetic research. Per Med. 2021 05; 18(3):311-327.
Score: 0.032
-
Roman YM, Dixon DL, Salgado TM, Price ET, Zimmerman KM, Sargent L, Slattum PW. Challenges in pharmacotherapy for older adults: a framework for pharmacogenomics implementation. Pharmacogenomics. 2020 06; 21(9):627-635.
Score: 0.030
-
Roman Y, Tiirikainen M, Prom-Wormley E. The prevalence of the gout-associated polymorphism rs2231142 G>T in ABCG2 in a pregnant female Filipino cohort. Clin Rheumatol. 2020 Aug; 39(8):2387-2392.
Score: 0.029
-
Roman YM. The Daniel K. Inouye College of Pharmacy Scripts: Perspectives on the Epidemiology of Gout and Hyperuricemia. Hawaii J Med Public Health. 2019 02; 78(2):71-76.
Score: 0.027
-
Roman YM. Race and precision medicine: is it time for an upgrade? Pharmacogenomics J. 2019 02; 19(1):1-4.
Score: 0.027
-
Pressly MA, Schuck R, Mummaneni P, Roman YM, Pacanowski M. Utilization of polygenic risk scores in drug development protocols. Pharmacogenomics. 2025 Feb-Mar; 26(3-4):75-79.
Score: 0.010
-
Ahmed MA, Krishna R, Rayad N, Albusaysi S, Mitra A, Shang E, Hon YY, AbuAsal B, Bakhaidar R, Roman YM, Bhattacharya I, Cloyd J, Patel M, Kartha RV, Younis IR. Getting the Dose Right in Drug Development for Rare Diseases: Barriers and Enablers. Clin Pharmacol Ther. 2024 Dec; 116(6):1412-1432.
Score: 0.010
-
Sargent L, Zimmerman KM, Mohammed A, Barrett MJ, Nawaz H, Wyman-Chick K, Mackiewicz M, Roman Y, Slattum P, Russell S, Dixon DL, Lageman SK, Hobgood S, Thacker LR, Price ET. Low-Income Older Adults' Vulnerability to Anticholinergic Medication-Associated Frailty. Drugs Aging. 2023 12; 40(12):1123-1131.
Score: 0.009
-
Diallo AF, Mackiewicz M, Sargent L, Roman YM, Slattum PW, Waters L, Bennett J, Battle K, Zanjani F, Gendron T, Winship J, Ford G, Falls K, Price ET, Parsons P, Chung J. Cultivating Relationships as a Community-Based Recruitment Strategy in Transdisciplinary Aging Research: Lessons From an Academic-Community Partnership. Fam Community Health. 2024 Jan-Mar 01; 47(1):32-40.
Score: 0.009
-
Wen YF, Brundage RC, Roman YM, Culhane-Pera KA, Straka RJ. Population pharmacokinetics, pharmacodynamics and pharmacogenetics modelling of oxypurinol in Hmong adults with gout and/or hyperuricemia. Br J Clin Pharmacol. 2023 10; 89(10):2964-2976.
Score: 0.009
-
J Sargent L, Mackiewicz M, Roman Y, Diallo A, Russell S, Falls K, Zimmerman KM, Dixon DL, Prom-Wormley E, Hobgood S, Lageman SK, Zanjani F, Price ET. The Translational Approaches to Personalized Health Collaborative: Pharmacogenomics for African American Older Adults. Clin Transl Sci. 2021 03; 14(2):437-444.
Score: 0.008
-
Peng K, Bjork J, Wen YF, Roman YM, Culhane-Pera K, Lo MX, Gertner E, Straka RJ. HLA-B*58: 01 carrier status of Hmong in Minnesota: first in Hmong genotyping for prevalence of this biomarker of risk for severe cutaneous adverse reactions caused by allopurinol. Pharmacogenet Genomics. 2020 02; 30(2):21-25.
Score: 0.007